BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
lobelia and tussilago share 5200 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.686 means 69% of the combined target set is bound by both compounds. The IDF-weighted score of 0.655 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do lobelia and tussilago have in common?
lobelia and tussilago share 5200 molecular targets with a Jaccard similarity of 69%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can lobelia and tussilago be combined?
lobelia and tussilago share 5200 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: lobelia or tussilago?
In the BiohacksAI corpus: lobelia has 38 PubMed-indexed studies, tussilago has 171 studies.